Welcome   Guest   [Login | Register] Sign in with Facebook Sign in with Google Sign in with Yahoo!
logoRelationalStocks.com
STOCK TICKER:

Details Of Insider Trading Activities
TransactionCompanyTickerInsiderShares TradedAvg.
Price
Total ValueFiling
2020-05-20
Sale
Surface Oncology, Inc.SURFNew Enterprise Associates 14, L.P.
10% owner
420,000$3.66$1,537,200
2020-03-16
Purchase
IMARA Inc.IMRANew Enterprise Associates 14, L.P.
10% owner
475,000$16.00$7,600,000
2020-03-06
Sale
CHAMPIONS ONCOLOGY, INC.CSBRNew Enterprise Associates 14, L.P.
10% owner
708,155$6.99$4,950,003
2020-02-10
Purchase
Casper Sleep Inc.CSPRNew Enterprise Associates 14, L.P.
10% owner
1,250,000$12.00$15,000,000
2019-11-12
Purchase
Galera Therapeutics, Inc.GRTXNew Enterprise Associates 14, L.P.
10% owner
416,666$12.00$4,999,992
2019-11-04
Purchase
Oyster Point Pharma, Inc.OYSTNew Enterprise Associates 14, L.P.
10% owner
935,000$16.00$14,960,000
2019-08-28
Sale
Mersana Therapeutics, Inc.MRSNNew Enterprise Associates 14, L.P.
10% owner
1,211$2.91$3,524
2019-03-05
Purchase
Mersana Therapeutics, Inc.MRSNNew Enterprise Associates 14, L.P.
10% owner
3,750,000$4.00$15,000,000
2018-09-07
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
3,000,000$1.67$5,010,000
2018-04-23
Purchase
Surface Oncology, Inc.SURFNew Enterprise Associates 14, L.P.
10% owner
133,333$15.00$1,999,995
2018-03-27
Purchase
Tracon Pharmaceuticals, Inc.TCONNew Enterprise Associates 14, L.P.
10% owner
707,964$2.70$1,911,502
2018-03-27
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
6,000,000$1.92$11,520,000
2018-03-26
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
571,164$1.90$1,085,211
2018-03-23
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
294,090$1.95$573,475
2018-03-22
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
869,574$1.90$1,652,190
2018-03-21
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
104,844$1.81$189,767
2017-11-27
Sale
APPIAN CORPAPPNNew Enterprise Associates 14, L.P.
10% owner
569,620$19.49$11,101,893
2017-11-20
Sale
APPIAN CORPAPPNNew Enterprise Associates 14, L.P.
10% owner
2,820,516$19.49$54,971,856
2017-07-03
Purchase
Mersana Therapeutics, Inc.MRSNNew Enterprise Associates 14, L.P.
10% owner
1,000,000$15.00$15,000,000
2017-03-27
Purchase
Adaptimmune Therapeutics PLCADAPNew Enterprise Associates 14, L.P.
10% owner
12,870,000$0.70$9,009,000
2016-11-29
Purchase
Tracon Pharmaceuticals, Inc.TCONNew Enterprise Associates 14, L.P.
10% owner
869,565$5.75$4,999,998
2016-07-29
Purchase
INTERLEUKIN GENETICS INCILIUGrowth Equity Opportunities Fund III, LLC
10% owner
20,120,724$0.10$2,012,072
2015-10-06
Purchase
Mirna Therapeutics, Inc.MIRNNew Enterprise Associates 14, L.P.
10% owner
857,142$7.00$5,999,994
2015-02-04
Purchase
Tracon Pharmaceuticals, Inc.TCONNew Enterprise Associates 14, L.P.
10% owner
500,000$10.00$5,000,000
2014-12-23
Purchase
INTERLEUKIN GENETICS INCILIUGrowth Equity Opportunities Fund III, LLC
10% owner
19,868,965$0.10$1,986,896
2013-08-06
Purchase
Loxo Oncology, Inc.LOXONew Enterprise Associates 14, L.P.
10% owner
230,769$13.00$2,999,997

1

*Data and information is provided for informational purposes only, and is not intended for trading purposes.*
*By accessing the Relationalstocks.com web site, a user agrees that RelationalStocks.com shall be not liable for any errors or delays in the content.*